武器化CRISPR/Cas9用于选择性消除具有异常基因组的细胞
Sara Tavella1, Alessia di Lillo2, Anastasia Conti3
1Institute of Molecular Genetics (IGM), National Research Institute (CNR), Pavia, Italy; IFOM ETS - The AIRC Institute of Molecular Oncology, Milan, Italy.
DNA repair
|May 4, 2025
概括
这项研究重新使用CRISPR/Cas9来消除异常细胞,通过向非功能性DNA序列. 这种新的方法避免损害健康细胞,证明了癌症和病毒感染的治疗潜力.
科学领域:
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
- 细胞生物学 细胞生物学
背景情况:
- 当前的癌症和病毒疗法往往会对正常组织造成非特异性毒性.
- 克里斯普尔/卡斯9基因编辑通常针对功能基因,限制了其应用.
- 在开发选择性消除不健康细胞而不损害健康细胞的疗法方面存在挑战.
研究的目的:
- 通过专注于非功能性基因组序列,重新利用CRISPR/Cas9技术进行向细胞消除.
- 证明CRISPR/Cas9在消除异常细胞方面的潜力,包括具有基因组改变或静态病毒DNA的细胞.
- 通过尽量减少对健康组织的非目标影响,克服当前治疗方法的局限性.
主要方法:
- 工程HeLa和RKO细胞与无促进剂的绿色光蛋白 (GFP) 构造以模拟异常的基因组序列.
- 在GFP序列中利用Cas9介导的双链断裂 (DSB) 触发细胞反应.
- 研究DNA损伤反应 (DDR) 激活和抑制DNA修复因子DNA依赖蛋白激酶 (DNA-PK) 的影响.
主要成果:
- 在GFP序列中,Cas9诱导的DSB导致细胞活力降低和死亡率增加.
- 观察到的细胞变化包括细胞大小增加,多核化和cGAS阳性微核的积累.
- 在药理上抑制DNA-PK时,发炎反应的激活和增强细胞死亡被注意到.
结论:
- 通过向非功能性DNA序列,CRISPR/Cas9可以有效地消除异常基因组的细胞.
- 这种方法提供了一个潜在的策略,以克服与传统疗法相关的非特异性毒性.
- 这些发现凸显了CRISPR/Cas9在通过选择性细胞切除治疗癌症和病毒感染等疾病方面的治疗前景.
相关概念视频
CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
CRISPR and crRNAs
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
CRISPR/Cas9 Genome Editing
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...


